Literature DB >> 15309721

Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.

Chuan-Yong Guo1, Jian-Ye Wu, Yun-Bin Wu, Min-Zhang Zhong, Han-Ming Lu.   

Abstract

AIM: To explore the effects of endothelin-1(ET-1) on hepatic stellate cells (HSCs) DNA uptake, DNA synthesis, collagen synthesis and secretion, inward whole-cell calcium concentration ([Ca2+]i) as well as the blocking effect of verapamil on ET-1-stimulated release of inward calcium (Ca2+) of HSC in vitro.
METHODS: Rat hepatic stellate cells (HSCs) were isolated and cultivated. 3H-TdR and 3H-proline incorporation used for testing DNA uptake and synthesis, collagen synthesis and secretion of HSCs cultured in vitro; Fluorescent calcium indicator Fura-2/AM was used to measure [Ca2+]i inward HSCs.
RESULTS: ET-1 at the concentration of 5X10(-8) mol/L, caused significant increase both in HSC DNA synthesis (2,247+/-344 cpm, P<0.05) and DNA uptake (P<0.05) when compared with the control group. ET-1 could also increase collagen synthesis (P<0.05 vs control group) and collagen secretion (P<0.05 vs control group). Besides, inward HSC [Ca2+]i reached a peak concentration (422+/-98 mol/L, P<0.001) at 2 min and then went down slowly to 165+/-51 mol/L (P<0.01) at 25 min from resting state (39+/-4 mol/L) after treated with ET-1. Verapamil (5 mol/L) blocked ET-1-activated [Ca2+]i inward HSCs compared with control group (P<0.05). Fura-2/AM loaded HSC was suspended in no Ca2+ buffer containing 1 mol/L EGTA, 5 min later, 10(-8) mol/L of ET-1 was added, [Ca2+]i inward HSCs rose from resting state to peak 399+/-123 mol/L, then began to come down by the time of 20 min. It could also raise [Ca2+]i inward HSCs even without Ca2+ in extracellular fluid, and had a remarkable dose-effect relationship(P<0.05). Meanwhile, verapamil could restrain the action of ET-1(P<0.05).
CONCLUSION: Actions of ET-1 on collagen metabolism of HSCs may depend on the transportation of inward whole-cell calcium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309721      PMCID: PMC4572195          DOI: 10.3748/wjg.v10.i18.2697

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  51 in total

Review 1.  Hepatic fibrosis: from bench to bedside.

Authors:  Detlef Schuppan; Yury Popov; Yury Porov
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

2.  Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide.

Authors:  X Gasull; R Bataller; P Ginès; P Sancho-Bru; J M Nicolás; M N Görbig; E Ferrer; E Badía; A Gual; V Arroyo; J Rodés
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

3.  Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis.

Authors:  N Nagasue; D K Dhar; A Yamanoi; Y Emi; J Udagawa; A Yamamoto; M Tachibana; H Kubota; H Kohno; T Harada
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

4.  Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healing.

Authors:  Rong Shao; Don C Rockey
Journal:  J Cell Physiol       Date:  2002-06       Impact factor: 6.384

5.  Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1.

Authors:  R M Reinehr; R Kubitz; T Peters-Regehr; J G Bode; D Häussinger
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

6.  Clinical significance of plasma endothelin-1 in patients with chronic liver disease.

Authors:  H Matsumoto; J Uemasu; M Kitano; H Kawasaki
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Isolation and culture of Kupffer cells from human liver. Ultrastructure, endocytosis and prostaglandin synthesis.

Authors:  A Brouwer; R J Barelds; A M de Leeuw; E Blauw; A Plas; S H Yap; A M van den Broek; D L Knook
Journal:  J Hepatol       Date:  1988-02       Impact factor: 25.083

8.  Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle.

Authors:  Karnam S Murthy; Huiping Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-02       Impact factor: 4.052

9.  Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics.

Authors:  S Møller; V Gülberg; J H Henriksen; A L Gerbes
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083

Review 10.  Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: what messages do acetylcholine, glutamate, and GABA transmit?

Authors:  L S Satin; T A Kinard
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

View more
  6 in total

1.  The expression of ETAR in liver cirrhosis and liver cancer.

Authors:  Juhong Deng; Yu Huang; Ran Tao; Xiangxue Fan; Hongyue Zhang; Hongyan Kong; Qiqing Song; Jiaquan Huang
Journal:  Cancer Biol Ther       Date:  2017-08-16       Impact factor: 4.742

2.  Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action.

Authors:  Wen-Ting Bin; Li-Mei Ma; Qing Xu; Xiao-Lin Shi
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

3.  Dynamic expression of extracellular signal-regulated kinase in rat liver tissue during hepatic fibrogenesis.

Authors:  Xiao-Lan Zhang; Jin-Ming Liu; Chang-Chun Yang; Yi-Lin Zheng; Li Liu; Zhan-Kui Wang; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

4.  Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa.

Authors:  Vidhya R Rao; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2008-03-12       Impact factor: 3.467

5.  Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation.

Authors:  N Kojima; M Hori; T Murata; Y Morizane; H Ozaki
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

Review 6.  Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis.

Authors:  Alfonsina Milito; Mariarita Brancaccio; Giuseppe D'Argenio; Immacolata Castellano
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.